Crinetics Pharmaceuticals Files 2024 10-K
Ticker: CRNX · Form: 10-K · Filed: Feb 27, 2025 · CIK: 1658247
| Field | Detail |
|---|---|
| Company | Crinetics Pharmaceuticals, Inc. (CRNX) |
| Form Type | 10-K |
| Filed Date | Feb 27, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, annual-report, pharmaceuticals
Related Tickers: CRNX
TL;DR
CRNX filed 2024 10-K. Full financials out.
AI Summary
Crinetics Pharmaceuticals, Inc. filed its 2024 10-K on February 27, 2025, reporting its fiscal year ending December 31, 2024. The company, based in San Diego, CA, operates in the pharmaceutical preparations sector. Key financial data and operational details for the fiscal year are presented in this filing.
Why It Matters
This filing provides a comprehensive overview of Crinetics Pharmaceuticals' financial health and business operations for the fiscal year 2024, crucial for investors and stakeholders to assess performance and future outlook.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Crinetics faces inherent risks related to drug development, regulatory approvals, and market competition, which are detailed in their 10-K filing.
Key Numbers
- 2024-12-31 — Fiscal Year End (The period covered by the financial statements.)
- 2025-02-27 — Filing Date (Date the 10-K was submitted to the SEC.)
Key Players & Entities
- Crinetics Pharmaceuticals, Inc. (company) — Filer of the 10-K
- 2024-12-31 (date) — Fiscal year end
- 2025-02-27 (date) — Filing date
- San Diego, CA (location) — Company headquarters
- Matthew Fust (person) — Mentioned in relation to a date range
- Sanwa Kagaku Kenkyusho Co., Ltd. (company) — Mentioned in relation to a date
FAQ
What is the primary business of Crinetics Pharmaceuticals, Inc.?
Crinetics Pharmaceuticals, Inc. is primarily involved in the Pharmaceutical Preparations industry, as indicated by its SIC code [2834].
When did Crinetics Pharmaceuticals, Inc. file its 2024 10-K report?
The company filed its 2024 10-K report on February 27, 2025.
What is the fiscal year end date for Crinetics Pharmaceuticals, Inc.?
The fiscal year end date for Crinetics Pharmaceuticals, Inc. is December 31, 2024.
Where is Crinetics Pharmaceuticals, Inc. headquartered?
Crinetics Pharmaceuticals, Inc. is headquartered at 10222 Barnes Canyon Road, Bldg. #2, San Diego, CA 92121.
What is the SEC file number for Crinetics Pharmaceuticals, Inc.?
The SEC file number for Crinetics Pharmaceuticals, Inc. is 001-38583.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on February 27, 2025 by Matthew Fust regarding Crinetics Pharmaceuticals, Inc. (CRNX).